Tag:
Epigenomics
Latest Headlines
Latest Headlines
Epigenomics, Qiagen enter colorectal cancer test agreement
Epigenomics and Qiagen have entered an option agreement allowing the latter to develop and potentially commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9

